Novel therapeutics for metastatic renal
โ
Thomas E. Hutson; Robert A. Figlin
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 136 KB
## Abstract The treatment of metastatic renal cell carcinoma (RCC) has changed dramatically during the past few years. Sunitinib malate, sorafenib tosylate, bevacizumab with interferon ฮฑ, temsirolimus, and everolimus have improved clinical outcomes in randomized phase 3 trials by inhibiting the vas